Plain-English translation of NCT07278206 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing repetitive transcranial magnetic stimulation (rTMS)—a non-invasive brain stimulation technique—to see if it can reduce severe fatigue and cognitive problems (like brain fog and concentration issues) in people with long COVID. Researchers will compare active brain stimulation to a placebo treatment to understand whether this approach actually works and how it might help the brain heal.
Fatigue and cognitive dysfunction are among the most disabling symptoms of long COVID, affecting work and quality of life. While early studies suggest brain stimulation might help, there isn't yet solid evidence from rigorous, controlled trials—and this study aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
You would receive multiple sessions of brain stimulation, delivered to a specific area of your scalp over about 30 minutes per session. Half the participants will receive active stimulation, and half will receive a placebo (sham) treatment that feels similar but delivers minimal stimulation—neither you nor the researchers will know which group you're in. You'll also complete brain imaging scans, blood tests, and questionnaires about your symptoms before, during, and after treatment to help researchers understand how and why the treatment works.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Netherlands